We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current GBIO market cap is 200.43M. The company's latest EPS is USD -1.9046 and P/E is -1.58.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 880k | 2.15M |
| Operating Income | -32.67M | -34.69M | -34.87M | -33.92M | -28.71M |
| Net Income | -31.31M | -32.41M | -32.09M | -31.07M | -28.27M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 5.9M |
| Operating Income | -62.3M | -81.11M | -119.1M | -141.18M | -138.56M |
| Net Income | -61.32M | -80.52M | -119.05M | -136.64M | -126.61M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 402.8M | 376.26M | 431.42M | 404.88M | 381.49M |
| Total Liabilities | 94.05M | 93.77M | 152.28M | 150.6M | 149.58M |
| Total Equity | 308.75M | 282.49M | 279.14M | 254.29M | 231.91M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 42.14M | 294.16M | 476.77M | 376.26M | 374.76M |
| Total Liabilities | 25.14M | 26.14M | 95.03M | 93.77M | 171.63M |
| Total Equity | -98.59M | 268.01M | 381.75M | 282.49M | 203.13M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -79.45M | -102.45M | -27.68M | -2.87M | -27.77M |
| Investing | -174.12M | -192.52M | -5.62M | 18.8M | -7.78M |
| Financing | 12.91M | 12.99M | 35.77M | 35.87M | 35.74M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -40.35M | -70.14M | -91.82M | -102.45M | -52.75M |
| Investing | 47.99M | -205.2M | 193.05M | -192.52M | -9.7M |
| Financing | 78k | 323.1M | 214.67M | 12.99M | 35.82M |
| Market Cap | 200.43M |
| Price to Earnings Ratio | -1.58 |
| Price to Sales Ratio | 33.78 |
| Price to Cash Ratio | 3 |
| Price to Book Ratio | 0.98 |
| Dividend Yield | - |
| Shares Outstanding | 66.48M |
| Average Volume (1 week) | 146.44k |
| Average Volume (1 Month) | 219.84k |
| 52 Week Change | -38.34% |
| 52 Week High | 6.98 |
| 52 Week Low | 0.86 |
| Spread (Intraday) | 0.07 (2.3%) |
| Company Name | Generation Bio Company |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.generationbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
